Astellas acquires Xyphos and its CAR-T technology for $665m
Astellas continues its acquisition spree in the advanced therapeutics space through a deal for Xyphos and its next-generation take on CAR-T therapies.
Archives for January 9, 2020
WuXi Biologics and Almirall partner to develop dermatological treatments
Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.
China approves first vaccine since adoption of tougher standards
Sinovac becomes first company to win approval for a vaccine in China since the adoption of tougher standards.